MedPath

Comparison between narcotic and non-narcotic drug in patients undergoing brain tumor surgery

Not Applicable
Conditions
Health Condition 1: C718- Malignant neoplasm of overlappingsites of brain
Registration Number
CTRI/2022/01/039670
Lead Sponsor
AIIMS Bhopal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Wh

Exclusion Criteria

Patients with morbid obesity

Patients who are not extubatable

Patients with anti-hypertensive medication

Patients with psychiatric disease

Pregnant women

Non-consenting patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe and estimate emergence time in opioid based (fentanyl) general anesthesia along with scalp block vs opioid sparing (dexmedetomidine) general anesthesia along with scalp block in patients undergoing supratentorial surgeriesTimepoint: 18 months
Secondary Outcome Measures
NameTimeMethod
1.To observe and estimate perioperative hemodynamic stability, in opioid based (fentanyl) general anesthesia along with scalp block vs opioid sparing (dexmedetomidine) general anesthesia along with scalp block in patients undergoing supratentorial surgeries. <br/ ><br> <br/ ><br>2.To observe and estimate postoperative recovery (modified aldrete score post operatively) in opioid based (fentanyl) general anesthesia vs opioid sparing (dexmedetomidine) general anesthesia in patients undergoing supratentorial surgeries. <br/ ><br> <br/ ><br>3.To observe and estimate patient and surgeon satisfaction, duration of the hospital stay in opioid based (fentanyl) general anesthesia vs opioid sparing (dexmedetomidine) general anesthesia in patients undergoing supratentorial surgeries. <br/ ><br>Timepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath